Fundraising Fox

CoreMap

Burlington, US · Founded 2016 · Delaware corporation · 3 known investors

CoreMap develops medical technology that lets physicians visualize atrial fibrillation (AF), an irregular heart arrhythmia, to inform better treatment options for patients. It targets cardiac electrophysiology and diagnostics.

BiotechDigital HealthHealthtechMedical Devices

Founders & leadership

CoreMap was founded in 2016 by Peter Spector and Sarah Kalil.

PSPeter Spector
Peter SpectorinCo-Founder, Inventor, Chief Scientific Officer & Chairman of the Board of Clinical and Scientific Advisors
SKSarah Kalil
Sarah KalilinCo-Founder, President & CEO

Board

AR
Adam RothsteinBoard director
AK
Allen KamerBoard director

Investors · 3

Dudley FundBurlington
P5 Health VenturesWestport

Also in the syndicate · 1

Medtroniclead

Reported raises · per SEC filings

Form D private placements

$75.3M disclosed across 6 rounds · 2017–2026

▶$35.5MraisedJun 2026 · 73 investors · Other Technology
Rule 506(b)
CoreMap Raises $37M in Series C Fundingfinsmes.com · Aug 2026Medtronic invests in CoreMap’s oversubscribed $37m Series C roundsiliconrepublic.com · Jul 2026
Officers, directors & promoters on the filing
  • Sarah KalilExecutive Officer, Director
  • Gowri RamanDirector
  • Allen KamerDirector
  • Adam RothsteinDirector
Offering amount
$45M
Amount sold
$35.5M
Minimum investment
$25K
Sales commissions
$500K
First sale
Jun 2026
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$6.8MraisedJul 2025 · 19 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Allen KamerDirector
  • Peter SpectorExecutive Officer, Director
  • Adam RothsteinDirector
  • Sarah O KalilExecutive Officer, Director
Offering amount
$30M
Amount sold
$6.8M
Minimum investment
$1K
First sale
Jul 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$23.2MraisedFeb 2022 · 26 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Allen KamerDirector
  • Sarah KalilExecutive Officer, Director
  • Peter SpectorDirector
  • Adam RothsteinDirector
Offering amount
$28M
Amount sold
$23.2M
First sale
Jan 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$8.9MraisedSep 2020 · 18 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • RONNY GINORDirector
  • ALLEN KAMERDirector
  • SARAH KALILExecutive Officer, Director
  • PETER SPECTORDirector
Offering amount
$8.9M
Amount sold
$8.9M
First sale
Sep 2020
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$500KraisedMay 2019 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Sarah KalilExecutive Officer, Director
  • Peter S SpectorDirector
  • William GruberDirector
Offering amount
$750K
Amount sold
$500K
Minimum investment
$25K
Proceeds to insiders
$125K
First sale
Apr 2019
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$300KraisedSep 2017 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Peter SpectorExecutive Officer, Director
  • Sarah KalilExecutive Officer
Offering amount
$500K
Amount sold
$300K
Minimum investment
$50K
Proceeds to insiders
$100K
First sale
Sep 2017
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 2

by search overlap
MetaMap enterprise-saas15 shared keywordsMetaMap provides an identity verification platform that lets businesses run KYC/AML compliance checks, customer onboarding, authentication, and financial risk assessment using a data pool drawing on government checks, financial records, and biometric verifications across many countries. It serves enterprises in sectors such as payments, insurance, and crypto.
Nearmap15 shared keywordsNearmap is a property intelligence company that provides aerial imagery, AI-derived risk analytics, and building materials data to insurance underwriters and claims teams for risk assessment and catastrophe response. The company serves property and casualty insurers across the United States and operates globally.

Companies competing with CoreMap for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

CoreMap Raises $37M in Series C Fundingfinsmes.com · Aug 2026Medtronic invests in CoreMap’s oversubscribed $37m Series C roundsiliconrepublic.com · Jul 2026CoreMap raises $37M in Medtronic-led funding round to advance atrial fibrillation mapping technologymed-tech.world · Jul 2026Medtronic (MDT) Leads $37 Million CoreMap Funding Round To Back AF Mapping System - Simply Wall St Newssimplywall.st · Jul 2026Medtronic invests in CoreMap’s oversubscribed $37m Series C roundsiliconrepublic.com · Jul 2026Trysignalbasetrysignalbase.com · Jul 2026CoreMap raises $37m in Medtronic-led financing round - Medical Device Networkmedicaldevice-network.com · Jul 2026Medtronic leads $37M Series C for AFib ablation mapping tech developer CoreMapmassdevice.com · Jul 2026

Frequently asked questions

What does CoreMap do?
CoreMap develops medical technology that lets physicians visualize atrial fibrillation (AF), an irregular heart arrhythmia, to inform better treatment options for patients. It targets cardiac electrophysiology and diagnostics.
Who founded CoreMap?
CoreMap was founded by Peter Spector, Sarah Kalil in 2016.
Who are CoreMap's investors?
CoreMap's investors include Dudley Fund, P5 Health Ventures.
How much funding has CoreMap raised?
CoreMap has disclosed $75.3M raised across 6 rounds.
Where is CoreMap headquartered?
CoreMap is headquartered in Burlington, US.